What’s Propelling Check-Cap Ltd. (CHEK) to Increase So Much?

April 17, 2018 - By Maria Brooks

Check-Cap Ltd. (NASDAQ:CHEK) Logo

The stock of Check-Cap Ltd. (NASDAQ:CHEK) is a huge mover today! The stock increased 15.92% or $0.6592 during the last trading session, reaching $4.7992. About 382,131 shares traded or 1568.48% up from the average. Check-Cap Ltd. (NASDAQ:CHEK) has declined 76.56% since April 17, 2017 and is downtrending. It has underperformed by 88.11% the S&P500.
The move comes after 5 months positive chart setup for the $7.73 million company. It was reported on Apr, 17 by Barchart.com. We have $5.14 PT which if reached, will make NASDAQ:CHEK worth $541,100 more.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of an ingestible imaging capsule that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers. The company has market cap of $7.73 million. The Company’s C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit that is designed to track the capsule and record imaging and positioning data; and C-Scan View, a personal computer software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. It currently has negative earnings.

Check-Cap Ltd. (NASDAQ:CHEK) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.